NRT
From IntFX
[edit] Profile
[edit] Company Overview
Novogen Limited is an Australian biotechnology company engaged in the pharmaceutical research and development, and manufacturing and marketing of health supplements. It operates subsidiary companies in three geographical areas: Australia/New Zealand, North America (including the United States and Canada) and Europe (including the United Kingdom and the Netherlands). The subsidiaries are involved in the selling and marketing of Novogen's dietary supplements, including Promensil, Trinovin and Rimostil. It operates, through its subsidiaries, in three segments: pharmaceutical division, which includes developing a portfolio of prescription drugs; Marshall Edwards, Inc., which is focused on the development of oncology (cancer) drugs, and consumer health division, which is engaged in developing a range of non-prescription products meeting important health needs of men and women. In October 2006, the Company licensed the United States rights to its Promensil and Trinovin brands to Natrol, Inc.
[edit] News/Discussion & Announcements
|
|
|
|
[edit] Upcoming Events
